Carboxypeptidase B1 in dialyzed chronic kidney disease patients
Abstract Carboxypeptidase B1 has long been known to be a pancreas-specific tissue enzyme. In this paper we focus on Carboxypeptidase B1 concentration measurement in dialyzed chronic kidney kidney disease patients and on the effect dialysis adequacy and regimen exert on its concentration. A total of...
Saved in:
Main Authors: | Matej Stančík, Marián Grendár, Marián Mokáň |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88332-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease
by: M. O. Pyatchenkov, et al.
Published: (2023-09-01) -
Atypical Hemolytic Uremic Syndrome with Eosinophilia and Purtscher-like Retinopathy: A Case Report
by: MEI Qimin, et al.
Published: (2024-12-01) -
Ankrd1 as a potential biomarker for the transition from acute kidney injury to chronic kidney disease
by: Hailin Li, et al.
Published: (2025-02-01) -
Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01) -
Chronic hepatitis B and risk of kidney involvement
by: M. V. Mayevskaya, et al.
Published: (2013-05-01)